To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

NCT01009242 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis
Rheumatoid Arthritis

Interventions

BIOLOGICAL: CDP6038
BIOLOGICAL: CDP6038
BIOLOGICAL: CDP6038
OTHER: Placebo IV
OTHER: Placebo SC
DRUG: CDP 6038 SC
DRUG: Methotrexate

Sponsor

UCB Pharma